Literature DB >> 6215075

Heterogeneity of the response of chronic lymphocytic leukemia cells to phorbol ester.

J Okamura, E W Gelfand, M Letarte.   

Abstract

The ability of the tumor promotor 12-0-tetradecanoylphorbol 13-acetate (TPA) to induce differentiation of leukemic cells was studied in 10 cases of chronic lymphocytic leukemia (CLL). An increase in modal volume and an enhancement of the capacity of te leukemic cells to stimulate in mixed lymphocyte reaction (MLR) was seen in the majority of cases. A significant increase in Ia expression was observed upon culture of leukemic cells with TPA in 6 of the 10 cases; 5 of these cases also showed an induction of cytoplasmic IgM production. Correlations between the phenotypic markers of the leukemic cells and their ability to respond to TPA were evaluated. CLL cells with low amounts to surface Ig. a volume less than or equal to 165 fl. and relatively low la expression responded well to TPA. Cells with bright surface Ig. a volume greater than or equal to 178 fl. and elevated amounts of Ia responded poorly to TPA. These results suggest that differences in the response of B leukemic cells to TPA reflect the underlying heterogeneity of the leukemic cells and might be correlated with their stage of maturation.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6215075

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  8 in total

1.  The role of cell maturation in the generation of phenotypic heterogeneity in B-cell chronic lymphocytic leukaemia.

Authors:  A H Maddy; A Sanderson; M J Mackie; S K Smith
Journal:  Immunology       Date:  1989-11       Impact factor: 7.397

2.  In-vitro induction of some features of hairy cell leukemia in chronic lymphocytic leukemia and immunocytoma cells.

Authors:  H W Ziegler-Heitbrock; B Dörken; R Munker; G Riethmüller; S Thierfelder; E Thiel
Journal:  Blut       Date:  1985-01

3.  Induction of plasmacytoid differentiation by phorbol ester in B-cell lymphoma cell lines bearing 8;14 translocations.

Authors:  D Benjamin; I T Magrath; T J Triche; R W Schroff; J P Jensen; S J Korsmeyer
Journal:  Proc Natl Acad Sci U S A       Date:  1984-06       Impact factor: 11.205

4.  Phorbol ester treated chronic B lymphocytic leukaemia cells induce autologous T cell proliferation without generation of cytotoxic T cells.

Authors:  D Kabelitz; T H Tötterman; K Nilsson; M Gidlund
Journal:  Clin Exp Immunol       Date:  1984-08       Impact factor: 4.330

5.  Phorbol ester-induced differentiation of chronic B lymphocytic leukaemia cells--regulatory impact of autologous and allogeneic accessory cells.

Authors:  A Danersund; T H Tötterman; K Nilsson; I Egle-Jansson; D Kabelitz; O Sjöberg
Journal:  Clin Exp Immunol       Date:  1985-03       Impact factor: 4.330

6.  Augmentation of mixed lymphocyte response. Stimulatory activity by phorbol ester.

Authors:  J Okamura; M Letarte; E W Gelfand
Journal:  J Clin Immunol       Date:  1984-05       Impact factor: 8.317

Review 7.  Expression of MHC class II antigens in human B-cell leukaemia and non-Hodgkin's lymphoma.

Authors:  K Guy; A S Krajewski; A E Dewar
Journal:  Br J Cancer       Date:  1986-02       Impact factor: 7.640

8.  Lymphocytic lymphoma/B-chronic lymphocytic leukaemia--an immunohistopathological study of peripheral B lymphocyte neoplasia.

Authors:  S H Swerdlow; L J Murray; J A Habeshaw; A G Stansfeld
Journal:  Br J Cancer       Date:  1984-11       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.